3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Liver Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Neoplasms
1
Colonic Neoplasms
1
Biliary Tract Neoplasms
1
Interventions
Gemcitabine
39
Cisplatin
24
Oxaliplatin
21
Capecitabine
20
Fluorouracil
11
Leucovorin
9
Irinotecan
9
130-nm albumin-bound paclitaxel
8
durvalumab
6
Taxes
5
Radiotherapy
5
Platinum
4
Immunohistochemistry
4
Erlotinib Hydrochloride
4
Docetaxel
4
Carboplatin
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
1,2-diaminocyclohexaneplatinum II citrate
4
trifluridine tipiracil drug combination
3
Trastuzumab
3
Sorafenib
3
Observation
3
Epirubicin
3
Drug Therapy
3
tremelimumab
2
toripalimab
2
regorafenib
2
pembrolizumab
2
anlotinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gallbladder Neoplasms
×
Camptothecin
×
Clear all
NCT03668418
2018-09-12
xenoZ
University of Pisa
Unknown
120 enrolled